Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BAY-3018250 by Bayer for Pulmonary Embolism: Likelihood of Approval
BAY-3018250 is under clinical development by Bayer and currently in Phase II for Pulmonary Embolism. According to GlobalData, Phase II...
BAY-3018250 by Bayer for Acute Ischemic Stroke: Likelihood of Approval
BAY-3018250 is under clinical development by Bayer and currently in Phase II for Acute Ischemic Stroke. According to GlobalData, Phase...
BAY-3018250 by Bayer for Deep Vein Thrombosis (DVT): Likelihood of Approval
BAY-3018250 is under clinical development by Bayer and currently in Phase II for Deep Vein Thrombosis (DVT). According to GlobalData,...